Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart

Rosiglitazone, a peroxisome proliferator-activated receptor γ agonist, has been used to treat type 2 diabetes. Despite debates regarding its cardioprotection, the effects of rosiglitazone on cardiac electrophysiology are still unclear. This study determined the effect of rosiglitazone on ventricular...

Full description

Saved in:
Bibliographic Details
Main Authors: Palee S., Weerateerangkul P., Surinkeaw S., Chattipakorn S., Chattipakorn N.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-79960699765&partnerID=40&md5=e9e031801fbf5b39d4096ac0b6ee3ca8
http://www.ncbi.nlm.nih.gov/pubmed/21666037
http://cmuir.cmu.ac.th/handle/6653943832/2635
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English